Skip to main content
OpenTrials
Completed

NCT Number: NCT00920244

In-hospital Cardiac Arrest - Dynamics and State Transitions

The purpose of this study is to analyse transitions in cardiac rhythm and hemodynamic variables during resuscitation of patients with in-hospital cardiac arrest.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

St.Olavs Hospital, Department of Anesthesia

Trondheim, 7014, Norway

About this study

In-hospital cardiac arrest carries a grave prognosis, with survival to discharge in the range of 15-20%. Key factors determining outcome include the presenting cardiac rhythm, aetiology, and early initiation of resuscitation. Some cardiac rhythms benefit from defibrillation (shockable rhythms). During resuscitation patients may switch between shockable and non-shockable rhythms, and may show signs of spontaneous circulation temporarily. Depending on rhythm and according to guidelines, patients receive direct current (DC) shocks (defibrillator) and/or i.v. adrenaline, atropine and amiodarone, which may affect state-transitions. We wish to make statistical analysis (time-series analysis, Markov modelling) of these state-transitions and variations in hemodynamic variables during resuscitation, related to CPR interventions and the cause of arrest. The cause of arrest will be determined based on chart records, interview with staff and autopsy if appropriate. One hypothesis is that differences in the patterns of state-transitions may reflect underlying aetiology, which may guide in future decision-making during resuscitation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with in-hospital cardiac arrest who are resuscitated

Exclusion criteria

  • Younger than 18 years old

Treatment and study plan

Cardiopulmonary resuscitation (CPR)

Procedure

CPR is performed according to international and national guidelines on all patients.

Other names: CPR

Epinephrine

Drug

According to guidelines epinephrine 1 mg i.v. is administered every 3 minutes during cardiopulmonary resuscitation.

Other names: Adrenaline

Atropine

Drug

According to CPR guidelines atropine 3 mg i.v. is administered if asystole og PEA with frequency < 60 beat/min.

Amiodarone

Drug

According to guidelines amiodarone 300 mg i.v. is administered if recurrent ventricular fibrillation/tachycardia (VF/VT) during CPR.

Other names: Cordarone

External defibrillator

Device

According to CPR guidelines patients with shockable rhythms may receive DC shocks. The defibrillator also stores physiological information regarding cardiac rhythm, pulse-oximetry, and end-tidal carbon dioxide (CO2) from endotracheal tube.

Other names: Defibrillator

Primary outcomes

  1. Survival to discharge

    Time frame: 1 year

Secondary outcomes

  1. Short-term survival

    Time frame: minutes-days

Sponsors and collaborators

Lead sponsor

St. Olavs Hospital

Other

Collaborators

  • Norwegian Air Ambulance Foundation
  • Norwegian University of Science and Technology

Registry information

Official study title

Dynamics and State Transitions During Resuscitation in In-hospital Cardiac Arrest

Important dates

Study start
2009
Primary completion
2015
Study completion
2015
First posted
Jun 15, 2009
Registry last updated
Sep 5, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.